Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
23
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Nochur Sara | Director | 8 | $0 | $0 | 2023-09-25 |
| Lee John Jui-Jen | Chief Development Officer | 7 | $0 | $0 | 2023-09-25 |
| Trask Anna | See Remarks | 14 | $0 | $120.1K | 2023-09-25 |
| Carson William H. | Director | 8 | $0 | $0 | 2023-09-25 |
| FINGER ALISON CECILY | Director | 8 | $0 | $0 | 2023-09-25 |
| Kapusta Matthew C | Director | 4 | $0 | $0 | 2023-09-25 |
| Reid Laurence | See Remarks | 8 | $76.4K | $0 | 2023-09-25 |
| MCLAUGHLIN KEVIN F | Director | 6 | $0 | $0 | 2023-09-25 |
| Exter Neil | Director, 10% Owner | 8 | $0 | $0 | 2022-06-17 |
| Thompson Peter A. | Director, 10% Owner | 10 | $30.00M | $0 | 2022-06-17 |
| Leiderman Elisabeth | Chief Financial Officer | 1 | $0 | $0 | 2022-02-25 |
| Hu Cynthia W. | General Counsel | 1 | $0 | $0 | 2021-08-16 |
| REGENERON PHARMACEUTICALS, INC. | 10% Owner | 3 | $0 | $0 | 2021-02-17 |
| Schroder Adveq cPl Global Management III L.P. | 10% Owner | 4 | $0 | $0 | 2021-02-17 |
| GV 2019 GP, L.L.C. | 10% Owner | 2 | $0 | $0 | 2021-02-17 |
| Foy Matthew | Director, 10% Owner | 8 | $2.70M | $0 | 2021-02-17 |
| GV 2017, L.P. | 10% Owner | 2 | $0 | $0 | 2021-02-17 |
| GV 2016, L.P. | 10% Owner | 2 | $0 | $0 | 2021-02-17 |
| Longevity Fund 2 LP | 10% Owner | 2 | $0 | $0 | 2021-02-17 |
| Casdin Partners Master Fund, L.P. | 10% Owner | 3 | $10.35M | $0 | 2021-02-17 |
| GLAXOSMITHKLINE PLC | Director | 7 | $2.70M | $0 | 2021-02-17 |
| ORBIMED ADVISORS LLC | Director, 10% Owner | 8 | $30.00M | $0 | 2021-02-17 |
| POON CHRISTINE A | Director | 1 | $0 | $0 | 2021-02-11 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Nochur Sara | Director | D To issuer deriv | 2023-09-25 | 2023-09-25 | 10,000 | — | $0 | 0 | SEC↗ |
| Nochur Sara | Director | D To issuer deriv | 2023-09-25 | 2023-09-25 | 20,000 | — | $0 | 0 | SEC↗ |
| Nochur Sara | Director | D To issuer deriv | 2023-09-25 | 2023-09-25 | 5,000 | — | $0 | 0 | SEC↗ |
| Kapusta Matthew C | Director | D To issuer deriv | 2023-09-25 | 2023-09-25 | 10,000 | — | $0 | 0 | SEC↗ |
| Reid Laurence | See Remarks | D To issuer deriv | 2023-09-25 | 2023-09-25 | 72,000 | — | $0 | 0 | SEC↗ |
| Reid Laurence | See Remarks | D To issuer deriv | 2023-09-25 | 2023-09-25 | 187,500 | — | $0 | 0 | SEC↗ |
| Reid Laurence | See Remarks | D To issuer deriv | 2023-09-25 | 2023-09-25 | 1,072,539 | — | $0 | 0 | SEC↗ |
| MCLAUGHLIN KEVIN F | Director | D To issuer deriv | 2023-09-25 | 2023-09-25 | 20,000 | — | $0 | 0 | SEC↗ |
| MCLAUGHLIN KEVIN F | Director | D To issuer deriv | 2023-09-25 | 2023-09-25 | 5,000 | — | $0 | 0 | SEC↗ |
| FINGER ALISON CECILY | Director | D To issuer deriv | 2023-09-25 | 2023-09-25 | 5,000 | — | $0 | 0 | SEC↗ |
| FINGER ALISON CECILY | Director | D To issuer deriv | 2023-09-25 | 2023-09-25 | 10,000 | — | $0 | 0 | SEC↗ |
| FINGER ALISON CECILY | Director | D To issuer deriv | 2023-09-25 | 2023-09-25 | 20,000 | — | $0 | 0 | SEC↗ |
| Lee John Jui-Jen | Chief Development Officer | D To issuer deriv | 2023-09-25 | 2023-09-25 | 52,500 | — | $0 | 0 | SEC↗ |
| Lee John Jui-Jen | Chief Development Officer | D To issuer deriv | 2023-09-25 | 2023-09-25 | 232,003 | — | $0 | 0 | SEC↗ |
| Lee John Jui-Jen | Chief Development Officer | D To issuer deriv | 2023-09-25 | 2023-09-25 | 45,000 | — | $0 | 0 | SEC↗ |
| Carson William H. | Director | D To issuer deriv | 2023-09-25 | 2023-09-25 | 20,000 | — | $0 | 0 | SEC↗ |
| Carson William H. | Director | D To issuer deriv | 2023-09-25 | 2023-09-25 | 5,000 | — | $0 | 0 | SEC↗ |
| Carson William H. | Director | D To issuer deriv | 2023-09-25 | 2023-09-25 | 10,000 | — | $0 | 0 | SEC↗ |
| Trask Anna | Chief People Officer | D To issuer deriv | 2023-09-25 | 2023-09-25 | 137,302 | — | $0 | 0 | SEC↗ |
| Trask Anna | Chief People Officer | D To issuer deriv | 2023-09-25 | 2023-09-25 | 52,500 | — | $0 | 0 | SEC↗ |
| Trask Anna | Chief People Officer | D To issuer deriv | 2023-09-25 | 2023-09-25 | 45,000 | — | $0 | 0 | SEC↗ |
| Nochur Sara | Director | D To issuer | 2023-09-25 | 2023-09-25 | 5,000 | — | $0 | 0 | SEC↗ |
| Kapusta Matthew C | Director | D To issuer | 2023-09-25 | 2023-09-25 | 10,000 | — | $0 | 0 | SEC↗ |
| Reid Laurence | See Remarks | D To issuer | 2023-09-25 | 2023-09-25 | 220,849 | — | $0 | 0 | SEC↗ |
| MCLAUGHLIN KEVIN F | Director | D To issuer | 2023-09-25 | 2023-09-25 | 5,000 | — | $0 | 0 | SEC↗ |
| FINGER ALISON CECILY | Director | D To issuer | 2023-09-25 | 2023-09-25 | 5,000 | — | $0 | 0 | SEC↗ |
| Lee John Jui-Jen | Chief Development Officer | D To issuer | 2023-09-25 | 2023-09-25 | 147,144 | — | $0 | 0 | SEC↗ |
| Carson William H. | Director | D To issuer | 2023-09-25 | 2023-09-25 | 5,000 | — | $0 | 0 | SEC↗ |
| Trask Anna | Chief People Officer | D To issuer | 2023-09-25 | 2023-09-25 | 106,864 | — | $0 | 0 | SEC↗ |
| MCLAUGHLIN KEVIN F | Director | A Award deriv | 2023-06-13 | 2023-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| FINGER ALISON CECILY | Director | A Award deriv | 2023-06-13 | 2023-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Carson William H. | Director | A Award deriv | 2023-06-13 | 2023-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Nochur Sara | Director | A Award deriv | 2023-06-13 | 2023-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| MCLAUGHLIN KEVIN F | Director | A Award | 2023-06-13 | 2023-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| FINGER ALISON CECILY | Director | A Award | 2023-06-13 | 2023-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Carson William H. | Director | A Award | 2023-06-13 | 2023-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Nochur Sara | Director | A Award | 2023-06-13 | 2023-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Kapusta Matthew C | Director | A Award deriv | 2023-03-19 | 2023-03-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Kapusta Matthew C | Director | A Award | 2023-03-19 | 2023-03-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Reid Laurence | See Remarks | A Award deriv | 2023-03-16 | 2023-03-17 | 72,000 | — | $0 | 72,000 | SEC↗ |
| Reid Laurence | See Remarks | A Award | 2023-03-16 | 2023-03-17 | 195,000 | — | $0 | 220,849 | SEC↗ |
| Lee John Jui-Jen | Chief Development Officer | A Award deriv | 2023-01-26 | 2023-01-30 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Trask Anna | Chief People Officer | A Award deriv | 2023-01-26 | 2023-01-30 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Lee John Jui-Jen | Chief Development Officer | A Award | 2023-01-26 | 2023-01-30 | 120,000 | — | $0 | 147,144 | SEC↗ |
| Trask Anna | Chief People Officer | A Award | 2023-01-26 | 2023-01-30 | 105,000 | — | $0 | 106,864 | SEC↗ |
| MCLAUGHLIN KEVIN F | Director | A Award deriv | 2022-10-10 | 2022-10-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Exter Neil | Director, 10% Owner | A Award deriv | 2022-06-17 | 2022-06-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Nochur Sara | Director | A Award deriv | 2022-06-17 | 2022-06-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Thompson Peter A. | Director, 10% Owner | A Award deriv | 2022-06-17 | 2022-06-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Carson William H. | Director | A Award deriv | 2022-06-17 | 2022-06-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FINGER ALISON CECILY | Director | A Award deriv | 2022-06-17 | 2022-06-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Reid Laurence | See Remarks | A Award deriv | 2022-02-25 | 2022-02-28 | 187,500 | — | $0 | 187,500 | SEC↗ |
| Leiderman Elisabeth | Chief Financial Officer | A Award deriv | 2022-02-25 | 2022-02-28 | 52,500 | — | $0 | 52,500 | SEC↗ |
| Lee John Jui-Jen | Chief Development Officer | A Award deriv | 2022-02-25 | 2022-02-28 | 52,500 | — | $0 | 52,500 | SEC↗ |
| Trask Anna | See Remarks | A Award deriv | 2022-02-25 | 2022-02-28 | 52,500 | — | $0 | 52,500 | SEC↗ |
| Trask Anna | See Remarks | S Sale | 2022-01-03 | 2022-01-04 | 377 | $5.03 | $1.9K | 1,864 | SEC↗ |
| Trask Anna | See Remarks | S Sale | 2022-01-03 | 2022-01-04 | 1 | $5.04 | $5 | 2,241 | SEC↗ |
| FINGER ALISON CECILY | Director | A Award deriv | 2021-12-03 | 2021-12-06 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Nochur Sara | Director | A Award deriv | 2021-12-03 | 2021-12-06 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Trask Anna | See Remarks | S Sale | 2021-12-02 | 2021-12-06 | 4,913 | $6.37 | $31.3K | 2,620 | SEC↗ |
| Trask Anna | See Remarks | S Sale | 2021-12-02 | 2021-12-06 | 378 | $6.34 | $2.4K | 2,242 | SEC↗ |
| Trask Anna | See Remarks | S Sale | 2021-11-03 | 2021-11-04 | 378 | $8.34 | $3.2K | 7,533 | SEC↗ |
| Trask Anna | SEE REMARKS | S Sale | 2021-11-02 | 2021-11-03 | 4,913 | $8.31 | $40.8K | 7,911 | SEC↗ |
| Trask Anna | See Remarks | S Sale | 2021-10-14 | 2021-10-15 | 5,364 | $7.55 | $40.5K | 12,824 | SEC↗ |
| Reid Laurence | President and Chief Executiv | P Buy | 2021-09-15 | 2021-09-17 | 10,000 | $7.64 | $76.4K | 25,849 | SEC↗ |
| Hu Cynthia W. | General Counsel | A Award deriv | 2021-08-16 | 2021-08-18 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Carson William H. | Director | A Award deriv | 2021-06-02 | 2021-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GV 2016, L.P. | 10% Owner | C Conversion deriv | 2021-02-17 | 2021-02-17 | 5,000,000 | — | $0 | 0 | SEC↗ |
| GV 2017, L.P. | 10% Owner | C Conversion deriv | 2021-02-17 | 2021-02-17 | 6,250,000 | — | $0 | 0 | SEC↗ |
| GV 2019 GP, L.L.C. | 10% Owner | C Conversion deriv | 2021-02-17 | 2021-02-17 | 4,344,048 | — | $0 | 0 | SEC↗ |
| REGENERON PHARMACEUTICALS, INC | 10% Owner | C Conversion deriv | 2021-02-17 | 2021-02-18 | 12,500,000 | — | $0 | 0 | SEC↗ |
| REGENERON PHARMACEUTICALS, INC | 10% Owner | C Conversion deriv | 2021-02-17 | 2021-02-18 | 14,000,000 | — | $0 | 0 | SEC↗ |
| Longevity Fund 2 LP | 10% Owner | C Conversion deriv | 2021-02-17 | 2021-02-18 | 79,143 | — | $0 | 0 | SEC↗ |
| GLAXOSMITHKLINE PLC | Director | C Conversion deriv | 2021-02-17 | 2021-02-19 | 1,737,619 | — | $0 | 0 | SEC↗ |
| GLAXOSMITHKLINE PLC | Director | C Conversion deriv | 2021-02-17 | 2021-02-19 | 3,125,000 | — | $0 | 0 | SEC↗ |
| GLAXOSMITHKLINE PLC | Director | C Conversion deriv | 2021-02-17 | 2021-02-19 | 7,119,850 | — | $0 | 0 | SEC↗ |
| Exter Neil | Director, 10% Owner | C Conversion deriv | 2021-02-17 | 2021-02-19 | 289,603 | — | $0 | 0 | SEC↗ |
| Exter Neil | Director, 10% Owner | C Conversion deriv | 2021-02-17 | 2021-02-19 | 1,250,000 | — | $0 | 0 | SEC↗ |
| Exter Neil | Director, 10% Owner | C Conversion deriv | 2021-02-17 | 2021-02-19 | 45,638,882 | — | $0 | 0 | SEC↗ |
| Thompson Peter A. | Director, 10% Owner | C Conversion deriv | 2021-02-17 | 2021-02-19 | 1,737,619 | — | $0 | 0 | SEC↗ |
| Thompson Peter A. | Director, 10% Owner | C Conversion deriv | 2021-02-17 | 2021-02-19 | 1,158,412 | — | $0 | 0 | SEC↗ |
| Thompson Peter A. | Director, 10% Owner | C Conversion deriv | 2021-02-17 | 2021-02-19 | 14,480,162 | — | $0 | 0 | SEC↗ |
| Casdin Partners Master Fund, L | 10% Owner | C Conversion deriv | 2021-02-17 | 2021-02-19 | 2,896,032 | — | $0 | 0 | SEC↗ |
| Foy Matthew | Director, 10% Owner | C Conversion deriv | 2021-02-17 | 2021-02-19 | 1,737,619 | — | $0 | 0 | SEC↗ |
| Foy Matthew | Director, 10% Owner | C Conversion deriv | 2021-02-17 | 2021-02-19 | 7,119,852 | — | $0 | 0 | SEC↗ |
| Foy Matthew | Director, 10% Owner | C Conversion deriv | 2021-02-17 | 2021-02-19 | 3,125,000 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2021-02-17 | 2021-02-19 | 14,480,162 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2021-02-17 | 2021-02-19 | 1,737,619 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2021-02-17 | 2021-02-19 | 1,158,412 | — | $0 | 0 | SEC↗ |
| Schroder Adveq cPl Global Mana | 10% Owner | C Conversion deriv | 2021-02-17 | 2021-03-08 | 6,625,001 | — | $0 | 0 | SEC↗ |
| Schroder Adveq cPl Global Mana | 10% Owner | C Conversion deriv | 2021-02-17 | 2021-03-08 | 6,625,001 | — | $0 | 0 | SEC↗ |
| GV 2016, L.P. | 10% Owner | C Conversion | 2021-02-17 | 2021-02-17 | 321,978 | — | $0 | 321,978 | SEC↗ |
| GV 2017, L.P. | 10% Owner | C Conversion | 2021-02-17 | 2021-02-17 | 494,649 | — | $0 | 494,649 | SEC↗ |
| GV 2019 GP, L.L.C. | 10% Owner | C Conversion | 2021-02-17 | 2021-02-17 | 819,631 | — | $0 | 819,631 | SEC↗ |
| REGENERON PHARMACEUTICALS, INC | 10% Owner | C Conversion | 2021-02-17 | 2021-02-18 | 2,097,314 | — | $0 | 2,097,314 | SEC↗ |
| Longevity Fund 2 LP | 10% Owner | C Conversion | 2021-02-17 | 2021-02-18 | 79,143 | — | $0 | 79,143 | SEC↗ |
| GLAXOSMITHKLINE PLC | Director | P Buy | 2021-02-17 | 2021-02-19 | 150,000 | $18.00 | $2.70M | 1,183,663 | SEC↗ |
| GLAXOSMITHKLINE PLC | Director | C Conversion | 2021-02-17 | 2021-02-19 | 458,487 | — | $0 | 458,487 | SEC↗ |
| GLAXOSMITHKLINE PLC | Director | C Conversion | 2021-02-17 | 2021-02-19 | 247,324 | — | $0 | 705,811 | SEC↗ |
| GLAXOSMITHKLINE PLC | Director | C Conversion | 2021-02-17 | 2021-02-19 | 327,852 | — | $0 | 1,033,663 | SEC↗ |
| Exter Neil | Director, 10% Owner | C Conversion | 2021-02-17 | 2021-02-19 | 54,642 | — | $0 | 3,139,685 | SEC↗ |
| Exter Neil | Director, 10% Owner | C Conversion | 2021-02-17 | 2021-02-19 | 98,929 | — | $0 | 3,085,043 | SEC↗ |
| Exter Neil | Director, 10% Owner | C Conversion | 2021-02-17 | 2021-02-19 | 2,938,945 | — | $0 | 2,986,114 | SEC↗ |
| Thompson Peter A. | Director, 10% Owner | C Conversion | 2021-02-17 | 2021-02-19 | 218,568 | — | $0 | 218,568 | SEC↗ |
| Thompson Peter A. | Director, 10% Owner | P Buy | 2021-02-17 | 2021-02-19 | 1,111,100 | $18.00 | $20.00M | 3,843,206 | SEC↗ |
| Thompson Peter A. | Director, 10% Owner | P Buy | 2021-02-17 | 2021-02-19 | 555,566 | $18.00 | $10.00M | 883,418 | SEC↗ |
| Thompson Peter A. | Director, 10% Owner | C Conversion | 2021-02-17 | 2021-02-19 | 327,852 | — | $0 | 327,852 | SEC↗ |
| Thompson Peter A. | Director, 10% Owner | C Conversion | 2021-02-17 | 2021-02-19 | 2,732,106 | — | $0 | 2,732,106 | SEC↗ |
| Casdin Partners Master Fund, L | 10% Owner | C Conversion | 2021-02-17 | 2021-02-19 | 546,421 | — | $0 | 546,421 | SEC↗ |
| Casdin Partners Master Fund, L | 10% Owner | P Buy | 2021-02-17 | 2021-02-19 | 575,000 | $18.00 | $10.35M | 1,121,421 | SEC↗ |
| Foy Matthew | Director, 10% Owner | P Buy | 2021-02-17 | 2021-02-19 | 150,000 | $18.00 | $2.70M | 1,183,663 | SEC↗ |
| Foy Matthew | Director, 10% Owner | C Conversion | 2021-02-17 | 2021-02-19 | 327,852 | — | $0 | 1,033,663 | SEC↗ |
| Foy Matthew | Director, 10% Owner | C Conversion | 2021-02-17 | 2021-02-19 | 247,324 | — | $0 | 705,811 | SEC↗ |
| Foy Matthew | Director, 10% Owner | C Conversion | 2021-02-17 | 2021-02-19 | 458,487 | — | $0 | 458,487 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion | 2021-02-17 | 2021-02-19 | 2,732,106 | — | $0 | 2,732,106 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | P Buy | 2021-02-17 | 2021-02-19 | 555,566 | $18.00 | $10.00M | 883,418 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion | 2021-02-17 | 2021-02-19 | 327,852 | — | $0 | 327,852 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion | 2021-02-17 | 2021-02-19 | 218,568 | — | $0 | 218,568 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | P Buy | 2021-02-17 | 2021-02-19 | 1,111,100 | $18.00 | $20.00M | 3,843,206 | SEC↗ |
| Schroder Adveq cPl Global Mana | 10% Owner | C Conversion | 2021-02-17 | 2021-03-08 | 524,328 | — | $0 | 524,328 | SEC↗ |
| Schroder Adveq cPl Global Mana | 10% Owner | C Conversion | 2021-02-17 | 2021-03-08 | 524,328 | — | $0 | 524,328 | SEC↗ |
| Thompson Peter A. | Director, 10% Owner | A Award deriv | 2021-02-11 | 2021-02-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Exter Neil | Director, 10% Owner | A Award deriv | 2021-02-11 | 2021-02-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| POON CHRISTINE A | Director | A Award deriv | 2021-02-11 | 2021-02-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Foy Matthew | Director, 10% Owner | A Award deriv | 2021-02-11 | 2021-02-16 | 20,000 | — | $0 | 20,000 | SEC↗ |